Genesis is one of the largest life science and healthcare networking conferences in London, held every December. Its organizers, One Nucleus and LINK-J, signed a Memorandum of Understanding (MOU) of partnership in December 2017, and LINK-J participates in Genesis every year.
The conference was conducted in a hybrid format. Senior executives and decision makers from the life sciences, technology and investment sectors joined as usual.
Innovation Workshop was held again this year before and after the Genesis. LINK-J hosted the workshop on Friday, December 10, from 7:00 pm to 8:00 pm Japan time (10:00 am local time)
Dr. Masashi Matsunaga (LINK-J Supporter / President & CEO of Biospire Japan Ltd. / Senior Consultant of Oxentia) and Aki Soyama (President and CEO, director of LINK-J) introduced the life science ecosystem in Japan. Following the introduction, each delegate gave a presentation.
Speakers（Order of Presentations）
"Energy for Life ~ Enabling functional Mitochondria as therapeutic agents"
Yosuke Matsumiya, LUCA Science Inc.
Takumitsu Akutsu, CUORiPS Inc.
"World leader for mycoplasma infectious diseases (MID)"
Kazuhiro Matsuda, M Bio Technology Inc.
"Rapidly Expanding MSC from 1 to 10"
Hideyuki Takahashi, PuREC Co. Ltd.
"Innovative & Proven, Space x Drug Discovery"
Shun Yamaguchi, Space BD Inc.
Participants were mainly UK investors, startups and large corporations. It was a valuable opportunity to interact with Genesis participants under this Covid-19 situation.
Click here to view the archived video of our workshop.